Connect with us

Hi, what are you looking for?

Jewish Business News


Jann Wenner sells 49 percent Rolling Stone stake to Singapore’s BandLab Technologies



Jann Wenner, the founder of Rolling Stone is selling 49 percent of the iconic music and rock culture magazine to a Singapore start-up, owned by a billionaire’s son to build the legendary brand in Asia and worldwide.

Terms of the deal were not disclosed but the remaining 51 percent stake in the magazine is owned by parent company Wenner Media.

It’s the first time Wenner has let outside investor in the 49-year-old biweekly print magazine. The deal reflects the situation of the industry fighting to stay relevant in an online age.

BandLab Technologies, led by 28-year old Meng Ru Kuok, son of billionaire, founder of the world’s largest palm oil company, Wilmar International Ltd. Kuok Khoon Hong. Under the terms of the deal, a fully-owned subsidiary called Rolling Stone international will be set up in Singapore and managed by Kuok.

Gus Wenner, Jann’s 26-year-old son, who is head of digital media,  expressed excitement in finding a strategic partner for Rolling Stone, adding: “We see an enormous opportunity to diversify the brand into new markets and new areas of business.”

Kuok, BandLab’s CEO said: “Rolling Stone’s impact on culture over the years has been immeasurable and I’m truly honored to be joining the team on the next phase of its journey. I look forward to working closely with Gus to take the brand bravely into the future to realize its global potential.”

Currently, Rolling Stone publishes 12 international editions in Australia, Argentina, Brazil, Colombia, France, Germany, India, Indonesia, Italy, Japan, Mexico and Russia.



Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.